erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Erythrasma D004894 1 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Esophagitis, Peptic D004942 4 associated lipids
Eye Diseases D005128 12 associated lipids
Factor X Deficiency D005171 2 associated lipids
Fecal Incontinence D005242 1 associated lipids
Femoral Fractures D005264 7 associated lipids
Fetal Membranes, Premature Rupture D005322 4 associated lipids
Fever D005334 35 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Carbonell N et al. Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. 2006 Am. J. Gastroenterol. pmid:16771939
Glupczynski Y and Burette A Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment. 1990 Am. J. Gastroenterol. pmid:2153337
Janssen P et al. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. 2013 Am. J. Gastroenterol. pmid:24005344
Chang AD et al. Bacillary angiomatosis associated with extensive esophageal polyposis: a new mucocutaneous manifestation of acquired immunodeficiency disease (AIDS). 1996 Am. J. Gastroenterol. pmid:8855753
VIRANUVATTI V and BISESHURARIT P Clinical trial of erythromycin in amebic liver abscess. 1955 Am. J. Gastroenterol. pmid:13228406
Hakkal HG Pseudomembraneous colitis associated with antibiotics. 1976 Am. J. Gastroenterol. pmid:1274934
Fiorucci S et al. Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term. 1994 Am. J. Gastroenterol. pmid:8147358
Resnick J et al. Delayed gastric emptying and postoperative ileus after nongastric abdominal surgery: part II. 1997 Am. J. Gastroenterol. pmid:9177505
Camilleri M The current role of erythromycin in the clinical management of gastric emptying disorders. 1993 Am. J. Gastroenterol. pmid:8424415
Keshavarzian A and Isaac RM Erythromycin accelerates gastric emptying of indigestible solids and transpyloric migration of the tip of an enteral feeding tube in fasting and fed states. 1993 Am. J. Gastroenterol. pmid:8424419
Mantides A et al. The effect of erythromycin in gastric emptying of solids and hypertonic liquids in healthy subjects. 1993 Am. J. Gastroenterol. pmid:8424420
Richards RD et al. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. 1993 Am. J. Gastroenterol. pmid:8424421
Bonacini M et al. Effect of intravenous erythromycin on postoperative ileus. 1993 Am. J. Gastroenterol. pmid:8424422
Ruffin WK Erythromycin: a postoperative jumpstart? 1994 Am. J. Gastroenterol. pmid:7909647
Portincasa P et al. The effect of acute oral erythromycin on gallbladder motility and on upper gastrointestinal symptoms in gastrectomized patients with and without gallstones: a randomized, placebo-controlled ultrasonographic study. 2000 Am. J. Gastroenterol. pmid:11151875
Kalkay MN et al. Campylobacter-induced toxic megacolon. 1983 Am. J. Gastroenterol. pmid:6613968
Masclee AA et al. Effect of erythromycin on gallbladder emptying in patients with antrectomy or truncal vagotomy. 1995 Am. J. Gastroenterol. pmid:7771433
Laine L and Jensen DM Management of patients with ulcer bleeding. 2012 Am. J. Gastroenterol. pmid:22310222
Tanaka M et al. Agranulocytosis induced by macrolide antibiotics. 1995 Am. J. Hematol. pmid:7847332
Singer DR et al. Drug hypersensitivity causing granulomatous interstitial nephritis. 1988 Am. J. Kidney Dis. pmid:3354573
Martínez-Maldonado M Postinfectious glomerulonephritis. 2000 Am. J. Kidney Dis. pmid:10636819
Mery JP and Kanfer A Alterations in pharmacokinetics and ototoxicity of erythromycin in renal failure. 1984 Am. J. Kidney Dis. pmid:6741942
Silang R et al. Prokinetic agents increase plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying. 2001 Am. J. Kidney Dis. pmid:11157368
Ross EA and Koo LC Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients. 1998 Am. J. Kidney Dis. pmid:9428453
Curtis LH et al. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. 2003 Am. J. Med. pmid:12586234
Cameron DJ Effectiveness of early Lyme disease treatment. 1993 Am. J. Med. pmid:8388627
Nattel S et al. Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism. 1990 Am. J. Med. pmid:2382671
Naot Y et al. IgM and IgG antibody response in two immunosuppressed patients with Legionnaires' disease. Evidence of reactivation of latent infection. 1982 Am. J. Med. pmid:6756135
Klein JO Emerging perspectives in management and prevention of infections of the respiratory tract in infants and children. 1985 Am. J. Med. pmid:4014286
Rudin JE et al. Failure of erythromycin in treatment of Legionella micdadei pneumonia. 1984 Am. J. Med. pmid:6607673
Sacristán JA and Soto J Erythromycin ototoxicity: methodology and conclusions. 1993 Am. J. Med. pmid:8430720
Wong KF et al. Psittacosis-associated hemophagocytic syndrome. 1991 Am. J. Med. pmid:1867249
Tablan OC and Reyes MP Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae pneumonia. 1985 Am. J. Med. pmid:4025379
DAVIS DS and ROMANSKY MJ Successful treatment of gonococcic endocarditis with erythromycin; review of the literature. 1956 Am. J. Med. pmid:13354638
Swanson DJ et al. Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia. 1992 Am. J. Med. pmid:1731511
Kugler JW et al. Nosocomial Legionnaires' disease. Occurrence in recipients of bone marrow transplants. 1983 Am. J. Med. pmid:6337488
Moellering RC Introduction: revolutionary changes in the macrolide and azalide antibiotics. 1991 Am. J. Med. pmid:1656735
Neu HC Clinical microbiology of azithromycin. 1991 Am. J. Med. pmid:1656736
Stamm WE Azithromycin in the treatment of uncomplicated genital chlamydial infections. 1991 Am. J. Med. pmid:1656737
Hooton TM A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. 1991 Am. J. Med. pmid:1656738
Friedland L et al. Ocular and pericardial involvement in Legionnaires' disease. 1984 Am. J. Med. pmid:6507461
Wing EJ et al. Successful treatment of Legionella micdadei (Pittsburgh pneumonia agent) pneumonia with erythromycin. 1981 Am. J. Med. pmid:7304656
Bolton WK et al. Ventriculojugular shunt nephritis with Corynebacterium bovis. Successful therapy with antibiotics. 1975 Am. J. Med. pmid:1163549
Stocks JM et al. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin. 1989 Am. J. Med. pmid:2690620
Dull JS et al. Successful treatment of gastroparesis with erythromycin in a patient with progressive systemic sclerosis. 1990 Am. J. Med. pmid:2220887
Watanakunakorn C Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. 1976 Am. J. Med. pmid:1045861
Bowler WA et al. Gastrointestinal side effects of intravenous erythromycin: incidence and reduction with prolonged infusion time and glycopyrrolate pretreatment. 1992 Am. J. Med. pmid:1546723
Bor DH and Himmelstein DU Endocarditis prophylaxis for patients with mitral valve prolapse. A quantitative analysis. 1984 Am. J. Med. pmid:6711576
Unertl KE et al. Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin. 1989 Am. J. Med. pmid:2589356
Trimble GX Acute pancreatitis induced by erythromycin. 1989 Am. J. Med. pmid:2589410